semaglutide glp GLP-1 Oral Semaglutide Gets FDA Approval

Septerna Sector: GPC Septerna R-targeted oral small molecule drug discovery, including GLP-1, GIP, and glucagon receptors HQ: South San Francisco, CA Year Founded: 2019 (under the name GPCR NewCo, Inc.)

Specifications First available: 12/2019 Shipping weight: 0.53 kg Product code: NRX-75525 UPC: 850005755258 Package quantity: 465 ml Dimensions: 21.8 x 6.5 x 6.4 cm , 0.53 kg Suggested use Shake well before opening

Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with type 2 diabetes and normal glucose tolerance

Y., Stothard, P

Avoid intense physical activity, alcohol consumption, and exposure to hot temperatures for at least 24 hours post-injection.